Global Natural Gas Liquids (NGLs) Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

The Natural Gas Liquids (NGLs) market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Natural Gas Liquids (NGLs) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Natural Gas Liquids (NGLs) Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Natural Gas Liquids (NGLs) market are: ExxonMobil Corp. Alkcon Corp. Chevron Corp. Royal Dutch Shell Plc Chesapeake Energy Corp. BP Plc Statoil ASA Anadarko Petroleum Corp. ConocoPhillips Company Canadian Natural Resources Limited Range Resources Corp. Linn Energy LLC SM Energy Swift Energy Company Most important types of Natural Gas Liquids (NGLs) products covered in this report are: Propane Ethane Isobutene Others Most widely used downstream fields of Natural Gas Liquids (NGLs) market covered in this report are: Petrochemicals Space Heating Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.